Ultimate Longevity Center:
The Due Diligence Report
They Don't Want You to Read
In December 2025, a new franchise launched promising to bring elite longevity science to everyday Americans. Before you write a check for up to $1.2 million, here is what the public record actually shows about who is behind it and who is selling it.
Two-host conversational version of this investigative report. ~30 minutes. Same facts. Same primary sources. Same legal framing — allegations identified as allegations, settlements identified as settlements. Free to share with attribution.
FROM: Senior Managing Director, Franchise Risk & Capital Advisory
DATE: May 18, 2026
SUBJECT: Operational and Regulatory Risk Assessment — Ultimate Longevity Center
1. The Institutional Context: Fragility of Pre-Launch Longevity Models
The longevity and wellness sector currently represents a high-growth asset class, yet it remains operationally immature and fraught with structural volatility. For institutional capital, the primary risk lies in “celebrity-driven” brand equity, where the public profiles of figures like Tony Robbins or Gary Brecka often obscure the underlying regulatory and structural health of the franchise system.
The PeerSense Framework — a three-tier pre-investment screen:
- Operating Locations: Verification of existing successful units across diverse markets.
- Item 19 Financial Performance Representations: Audited data reflecting actual earnings of current franchisees.
- Regulatory History: A clean record for the franchisor and its principals, free from material federal settlements or fraud litigation.
Ultimate Longevity Center fails all three tiers.
2. Executive Integrity Audit: Regulatory History and Litigious Footprints
The Geisler Record — Federal Findings and Governance Failures. Anthony Geisler, operational architect of ULC through Sequel Brands, carries a significant regulatory footprint from his tenure as CEO of Xponential Fitness:
- $17M FTC settlement — largest consumer redress in agency franchise-enforcement history; FTC verbatim: “Geisler has been repeatedly sued for fraud.”
- $22.75M class action — finalized with 509 current and former franchisees.
- Board removal as CEO, May 2024, amid notice of federal criminal probe from the USAO (Central District of CA).
- Mitigating fact disclosed in full: Xponential settled without admitting liability. SEC investigation closed July 2025 with no enforcement action.
Brecka Credentials Audit. B.S. in Biology + B.S. in Human Biology. No medical degree, no clinical license. Professional background: life insurance mortality underwriting. The Cardone Ventures federal lawsuit alleging $100M in competing-business fraud was voluntarily dismissed by joint agreement — this is not judicial exoneration. The CFO resignation letter remains in the public court record. McGill University’s Office for Science and Society found no peer-reviewed support for specific public claims.
Robbins Association. Co-founder and spokesperson for Lifeforce, not CEO. Operational leadership: Dugal Bain-Kim (CEO), Courtney Reum (Board Chair, M13 VC). Robbins is involved in 140+ businesses — presence does not equate to personal vetting.
3. Financial Performance Void: The 120-0 Disconnect
Ultimate Longevity Center has currently sold 120 franchise licenses, yet as of the January 2026 FDD, there are zero operating locations open. There is no historical data to support the revenue claims made in marketing materials.
| Franchise | Operating Units | Median Item 19 Revenue | Royalty + Fees |
|---|---|---|---|
| VIO Med Spa | 56 | $1,186,907 | 6.0% |
| Relive Health | 172 | $802,132 | 5.0% |
| Ultimate Longevity Center | 0 | No Data | 10.0% effective (8% royalty + 2% brand + $850/mo tech) |
Marketing materials use the word “proven” six times. The FDD’s “if any” disclaimer is the legally required admission that no Item 19 data exists. The brand is also not on the SBA Franchise Directory — standard 10% down SBA financing is unavailable.
4. Structural Economic Erosion: The Race to the Bottom
- GLP-1 pricing collapse: $600-$700/mo at concierge clinics in 2024 → $99/mo at telehealth and compounding pharmacies in 2026.
- Sustainability math: At $99/mo, ULC’s 10% top-line fee structure plus clinical compliance and medication COGS effectively erases unit-level margin.
- Gender-specific retention risks: Male-skewed Brecka/Robbins marketing → higher conversion friction → higher Customer Acquisition Cost.
- Regulatory media war: Big Pharma’s campaign against compounded peptides creates asymmetric risk — tightening favors scale telehealth, kills franchisee units.
5. The Capitalization Gap: Burn Rate vs. Headline Investment
- Marketing requirement: $40K-$50K per month in ad spend to reach scale.
- True capital need: $1.5M-$2M including 18-24 months of operational ramp equity — far above the $508K-$1.18M FDD headline.
- Broker incentive gap: Franchise consultants earn $26K-$32K per placement, creating a financial disincentive to flag Geisler’s FTC history or Brecka’s litigation.
Strategic conclusion: Investing in ULC at this stage is not buying a system — it is providing the operational ramp-up equity for a brand experiment.
6. Final Risk Determination
Ultimate Longevity Center fails the PeerSense due-diligence screen on every institutional metric:
- Transparency deficiency. The 120-0 ratio indicates a massive lag in operational execution. The “proven model” claim is a marketing abstraction, not financial reality.
- Principal regulatory baggage. $39.75M in settlements from prior leadership plus verbatim federal findings of concealed fraud litigation create unacceptable reputational and regulatory risk.
- Deteriorating unit economics. GLP-1 commoditization to $99/mo + aggressive 10% top-line fee + $50K/mo marketing burn → high probability of capital depletion before break-even.
Recommendation: No-go. Primary-source documentation of profitable, franchisee-operated units must take precedence over celebrity narratives before this brand can be considered an institutional-grade asset.
Anthony Geisler took a company public on the New York Stock Exchange. That company paid nearly $40 million to settle FTC fraud allegations and a class action from over 500 franchisees. His own board removed him as CEO amid a federal criminal probe. He then launched a new franchise company. That franchise is now being sold for up to $1.2 million per location. Not a single location has opened.
This report documents the public record on the Ultimate Longevity Center franchise, its principals, and the network of consultants promoting it. Every claim is sourced to a primary document. Allegations are identified as allegations. Settlements are identified as settlements.
What You Are Actually Buying
On December 8, 2025, Sequel Brands announced the launch of Ultimate Longevity Center on PR Newswire. The concept promises red light therapy, hyperbaric chambers, biomarker testing, IV therapy, peptide protocols, and a curated supplement apothecary under one roof.
According to the January 8, 2026 Franchise Disclosure Document:
| Term | Amount |
|---|---|
| Total initial investment | $508,778 to $1,182,187 |
| Franchise fee | $65,000 |
| Royalty | 8% of gross revenue |
| Brand fund | 2% of gross revenue |
| Technology fee | $850 per month |
| Combined ongoing cost off revenue | 10%+ before rent or payroll |
| Minimum liquid capital required | $150,000 |
| Minimum net worth required | $1,000,000 |
| Locations open as of FDD date | ZERO |
| Item 19 earnings data | NONE EXISTS |
| SBA registry | NOT LISTED |
The "Proven Model" Problem
The Sequel Brands franchise sales page uses the word "proven" six times. It describes "a proven, scalable model" and "a proven brand." When a prospective investor asks the most important question on that same page, here is the answer they receive:
Q: How much can I make?
"Financial performance representations, if any, are included in Item 19 of our FDD. We do not discuss earnings outside the FDD in compliance with franchise law."
The phrase "if any" is the legally required admission that no Item 19 data exists. A proven model has documented operating results. This franchise has zero open locations.
What Comparable Operating Franchises Actually Produce
| Franchise | Units Open | Item 19 Median Revenue | Royalty | SBA Registered |
|---|---|---|---|---|
| VIO Med Spa | 56 | $1,186,907 | 6% | Yes |
| Relive Health | 172 | $802,132 | 5% | Yes |
| Ultimate Longevity Center | 0 | No data | 8% | No |
VIO Med Spa and Relive Health data from PeerSense franchise database, 2025-2026 FDDs. With comparable brands, you can call franchisees. Their contact information is in the FDD. With Ultimate Longevity Center, there are no franchisees to call.
Anthony Geisler: The Documented Federal Record
Anthony Geisler is named in the December 2025 PR Newswire launch announcement as the operational architect of Ultimate Longevity Center through Sequel Brands. He is the same Anthony Geisler who served as founder and CEO of Xponential Fitness until May 2024.
He Took a Company Public on the NYSE
On July 23, 2021, Xponential Fitness completed its IPO on the New York Stock Exchange under ticker XPOF, raising $120 million. Geisler was founder and CEO at the time. Every regulatory and legal consequence documented below occurred under his leadership of a publicly traded company.
Source: SEC Form 424B4, July 2021
The FTC Settlement: Largest in Franchise Enforcement History
On concealing Geisler's fraud history: "Xponential failed to disclose to prospective franchisees that former CEO Anthony Geisler was involved in the sale or operation of franchises and that he was involved in litigation that Xponential was legally required to disclose under the Franchise Rule. Specifically, the company failed to disclose that Geisler has been repeatedly sued for fraud."
On misrepresenting opening timelines: "Xponential falsely claimed that franchisees typically get their franchise studios up and running within six months of signing the franchise agreement. In reality, franchisees have typically taken more than a year after signing, if they opened at all."
The settlement: "$17 million — the most consumer redress in the agency's history for an alleged Franchise Rule violation."
Source: FTC.gov press release, March 18, 2026 · FTC case page
A separate franchisee class action settlement of $22.75 million was finalized with 509 current and former franchisees. Combined total paid in settlements under Geisler's leadership: approximately $39.75 million.
Source: Franchise Times, March 18, 2026
— Federal Trade Commission, March 18, 2026
Removed as CEO Amid Federal Criminal Probe
On May 10, 2024, Xponential's board removed Geisler as CEO and suspended him indefinitely, effective immediately. The company simultaneously disclosed a federal criminal investigation notice from the U.S. Attorney's Office for the Central District of California. Xponential's stock fell nearly 32% that day.
Source: Xponential 8-K, Business Wire, May 10, 2024 · Athletech News
The SEC opened a separate investigation into Xponential in December 2023. That investigation closed July 1, 2025 with no enforcement action taken. This is a material fact and is disclosed here in full. The SEC closure does not affect the FTC's $17 million consent order, nor does it affect the USAO criminal probe, which remained ongoing as of the most recent reporting.
Source: Orange County Business Journal, July 2, 2025
Geisler launched Sequel Brands and the Ultimate Longevity Center franchise approximately seven months after his removal from Xponential. He is now selling franchises again.
Gary Brecka: Credentials, Litigation, and Scientific Claims
What His Credentials Actually Are
Gary Brecka holds a Bachelor of Science in Biology from Frostburg State University and a Bachelor of Science in Human Biology from the National University of Health Sciences, formerly the National College of Chiropractic. He holds no medical degree and no clinical license. "Human biologist" is a self-applied title that is not a regulated or licensed professional designation in any U.S. state. His background before wellness influencing was mortality analysis in life insurance underwriting.
Source: InsuranceNewsNet, February 2025, citing court documents
The Lawsuits
On December 26, 2024, Cardone Ventures and 10X Health Ventures filed a federal lawsuit in the Southern District of Florida against Gary Brecka, his wife Sage Workinger, and affiliated entities, assigned to Chief U.S. District Judge Cecilia Altonaga.
Source: Yahoo Finance/PR Newswire, December 28, 2024
On March 17-18, 2025, two additional lawsuits were filed in Florida and Delaware state courts alleging Brecka "perpetrated a premeditated and massive fraud over an 18-month period."
The allegations state that while Brecka's contract required "substantially all" of his time to be devoted to 10X Health, he used 10X Health assets and personnel to secretly build competing businesses valued at $100 million, earning over $13 million in 2024 alone. The resignation letter of Brecka's own CFO, filed as a public court exhibit, states structures were built "specifically to circumvent the non-compete provisions" and describes Brecka threatening to "burn me and my family to the ground."
Source: PR Newswire, Cardone Ventures, March 18, 2025
The federal lawsuit was voluntarily dismissed by joint agreement before trial. No court made a finding on the merits in either direction. A voluntary joint dismissal is not a ruling that the allegations were false. Brecka did not receive a judgment in his favor. The CFO resignation letter remains in the public court record. The state lawsuits remained active as of April 2025. Brecka filed his own counterclaims alleging predatory conduct by Cardone Ventures.
Source: InsuranceNewsNet, April 27, 2025
Scientific Claims Under Independent Review
McGill University's Office for Science and Society published an independent analysis of Brecka's public health claims in November 2025, finding no peer-reviewed scientific support for specific claims he has made publicly, including statements about breast cancer and autoimmune disease.
Source: McGill University OSS, November 27, 2025
Watch: The Franchise Insiders Promote ULC Without Disclosing Any of This
This is the February 2, 2026 promotional episode featuring only Sequel Brands' Chief Sales Officer as a guest. In 42 minutes, no mention was made of Geisler's FTC settlement, Brecka's lawsuits, the criminal probe, or zero open locations.
The Real Cost of Running One of These Clinics
Most prospective franchisees focus on the FDD’s headline investment number. The actual capital required to give the unit a fighting chance is roughly double, the marketing burn is two to three times what under-capitalized operators run, and the highest-margin service in the offering — GLP-1 weight loss — is being commoditized in real time.
Big Pharma media war: The pharmaceutical industry is running sustained media campaigns against compounded peptides citing “unregulated dangers,” while their own FDA-approved GLP-1 drugs carry suicidal ideation, severe pancreatitis, gallbladder disease, and in some cases death on the label. The regulatory tightening risk is asymmetric — favors $99/month telehealth scale players, kills individual franchise units with two hundred members and a five thousand dollar monthly ad spend.
Lifeforce and Tony Robbins: Who Actually Runs This Company
The Ultimate Longevity Center is marketed as being powered by Lifeforce, "co-founded by Tony Robbins." Here is the actual corporate structure from primary source documents:
| Role | Person |
|---|---|
| CEO | Dugal Bain-Kim |
| Board Chairman | Courtney Reum, co-founder of M13 venture capital |
| Lead investors | M13 and Peterson Ventures (co-led Series A) |
| Incubated by | M13's in-house venture studio, Launchpad |
| Co-founders | Tony Robbins, Dr. Peter Diamandis, Dugal Bain-Kim |
Source: Business Wire, Lifeforce Series A press release, May 23, 2023
The board chairman is a venture capitalist. The CEO is not Tony Robbins. Robbins is a co-founder and public spokesperson. He has described himself as a founder, partner, or investor in over 140 privately held businesses. Nothing in publicly available records indicates Robbins personally conducted due diligence on Geisler's regulatory history or Brecka's litigation record before his name was attached to this offering.
Who Is Selling This — And What They Are Not Telling You
Every franchise consultant and broker listed below earns approximately $26,000 to $32,500 per placement, paid by Sequel Brands, not by the investor. None of the content analyzed below discloses this financial relationship.
The Franchise Insiders (Jack and Jill Johnson)
The Franchise Insiders podcast describes itself as "The #1 Franchise Podcast by Real Franchise Owners" and states its hosts "tell you no when needed" and would "rather lose your business than watch you fail." Their February 2, 2026 episode featured Sequel Brands Chief Sales Officer Jen Cain as the sole guest with no independent perspective. They called ULC "a once-in-a-generation category shift." They created scarcity with "200+ leads in 2 weeks. Only 600 U.S. territories." Their website offers a $5,000 discount on the franchise fee, funded by the commission Sequel Brands pays them at signing.
Jen Cain stated in that episode: "Consumers are more savvy than ever. Everything is at their fingertips. They can research brands, people, backgrounds."
She is correct. You just did.
| Promoter | 0 Locations | No Item 19 | Geisler FTC | Criminal Probe | Brecka Suits | Commission |
|---|---|---|---|---|---|---|
| Sequel Brands (own site) | No | Implicit | No | No | No | N/A |
| The Franchise Insiders | No | No | No | No | No | No |
| FranNet | No | No | No | No | No | No |
| IFPG | Yes | Yes | No | No | No | No |
| Franchise Sidekick | Yes | Yes | No | No | No | No |
| Longevity.Technology | Partial | No | No | No | No | Unknown |
Evidence Archived — Wayback Machine — May 18, 2026
All pages below are permanently preserved. Even if deleted or edited, these archived versions cannot be altered by any party.
- Franchise Insiders YouTube video — archived May 18, 2026
- Sequel Brands "proven model" page — archived May 18, 2026
- IFPG listing: 120 sold, 0 open — First Archive, May 18, 2026
- FranNet "Verified Brand" page — First Archive, May 18, 2026
- Franchise Insiders podcast transcript — First Archive, May 18, 2026
- Franchise Insiders ULC sales page ($5K offer) — First Archive, May 18, 2026
- Franchise Sidekick SeeThrough listing — First Archive, May 18, 2026
Standard Due Diligence Checklist: How ULC Scores
- ✕Can you visit an operating location?No. Zero locations open anywhere in the United States as of January 2026 FDD.
- ✕Does Item 19 disclose real earnings from real franchisees?No. No data exists. The franchisor's own FAQ confirms this with the words "if any."
- ✕Can you call existing franchisees listed in the FDD?No. There are no franchisees operating. There is no contact list.
- ✕Does the key executive have a clean regulatory history?No. The FTC found Geisler's prior fraud litigation was required to be disclosed to franchisees and was not. His prior company paid $39.75M in settlements.
- ✕Is the brand face free of major business litigation?No. Gary Brecka was the defendant in federal and state lawsuits alleging an 18-month fraud scheme. The federal suit was voluntarily dismissed before trial with no court finding on the merits.
- ~Does the brand face hold credentials matching his claims?Partially. Two undergraduate biology degrees. No medical degree, no clinical license. "Human biologist" is self-applied and unregulated.
- ✕Is the brand SBA-approved for financing?No. Not listed in the SBA franchise registry. Standard SBA financing not available.
- ✕Is the royalty competitive with comparable operating brands?No. 10%+ off gross revenue vs. 7.5-8% at VIO Med Spa and Relive Health, which have actual operating data to justify their fees.
Three Practical Paths Forward
This report stops at the documented record. What you do with it depends on where you are in your evaluation. Three reader paths, each editorial, each independent of any paid relationship with the parties named in this report.
Use the 8-question due diligence checklist in Section 06 against the current FDD. Request the January 2026 FDD directly from Sequel Brands. Call the FDD attorney listed in Item 23 and ask every checklist question. Read the FTC press release on ftc.gov yourself. Read the McGill University analysis. Read the IFPG listing. Form your own conclusion from primary sources.
If you spot a factual error in this report, the corrections email is in Section 09. Genuine errors with primary-source documentation are corrected within five business days.
PeerSense maintains operating-data profiles on the comparable brands referenced throughout this report — VIO Med Spa (56 units, $1.18M median revenue, SBA registry), Relive Health (172 units, $802K median, SBA registry), The DRIPBaR (106 units, $347K median, 46 SBA loans funded), Restore Hyper Wellness (85 units, 102 SBA loans), and others.
Each profile pulls live FDD data, Item 19 disclosures, SBA lending performance, and franchise-rule litigation history. PeerSense was not paid by any of the brands compared in this article. The data is what it is.
PeerSense is an independent capital advisory firm. We place senior debt for well-capitalized commercial real estate sponsors and business acquisition buyers — CMBS, bridge, hotel, DSCR rental, asset-based lending, equipment, factoring, and partner buyouts. Deal sizes from $500,000 to $500M+.
On SBA financings, advisory fees are paid by the lender at closing. On non-SBA financings (CMBS, bridge, DSCR, ABL, partner buyouts), fee structures vary by deal — typically a combination of lender-paid placement fees, borrower-paid advisory fees, or success-fee arrangements. PeerSense is not paid by Sequel Brands, the Ultimate Longevity Center, or any party named in this report.
PeerSense's primary business is capital advisory — sourcing senior debt for commercial real estate sponsors and business acquisition buyers. We also operate a franchise intelligence database (6,300+ brands, 899+ SBA lenders) and maintain franchise placement relationships with a small, select group of brands. None of the brands or principals named in this report fall into that group, and PeerSense was not paid by any party in this article to publish it.
Every Question People Are Searching For, Answered
Every Source. Every URL. Read It Yourself.
Found a Factual Error? Tell Us.
This report is based exclusively on publicly available primary source documents — federal agency filings, SEC records, Business Wire and PR Newswire releases distributed for editorial use, court records, university research publications, and the PeerSense franchise_profiles database drawn from publicly filed FDDs. The report contains no opinions, no speculation, and no characterizations beyond what the primary sources directly state.
If you are a person, entity, or representative thereof named in this article and you believe a specific factual claim is inaccurate, incomplete, or has been superseded by newer public-record information, contact us with the following:
1. The specific sentence or claim you dispute (quote it).
2. A primary source document — a federal agency filing, court record, SEC filing, or similar — that contradicts or contextualizes it.
Genuine factual errors will be corrected promptly and the correction will be timestamped. Updates to the public record (newly settled cases, dismissed charges, exoneration findings, or post-publication court rulings) will be reflected as they enter the public domain. We will reply within 5 business days.
Contact: info@peersense.com · Subject line: “Correction Request — Ultimate Longevity Center Franchise Review”
What We Do Not Do
PeerSense does not publish a reader-comment section on this article. We do not host third-party opinions or unverified claims. Discussion of this report is welcome on independent third-party platforms; legitimate factual corrections route through the email address above. PeerSense does not characterize any individual as guilty of a crime, nor as a "scammer," nor as a "fraudster." Where federal agencies have made factual findings, we quote those findings verbatim and link to the source. Readers form their own conclusions from the documented record.
Editorial Independence Statement
PeerSense's primary revenue is capital advisory work — placement of senior debt for commercial real estate sponsors and business acquisition buyers across CMBS, bridge, hotel, DSCR rental, asset-based lending, equipment, factoring, and partner buyout deals. On SBA financings, advisory fees are paid by the lender at closing. On non-SBA financings, fee structures vary by deal and may be lender-paid, borrower-paid, or structured as success fees. PeerSense additionally operates a franchise intelligence database and maintains franchise placement relationships with a small, select group of brands. None of the brands or principals named in this report — including Sequel Brands, Ultimate Longevity Center, Anthony Geisler, Gary Brecka, Tony Robbins' Lifeforce, or any of the franchise consultants documented in Section 05 — are part of that group, and none has any financial, advertising, or contemplated relationship with PeerSense, present or past. PeerSense was not paid by any party to publish this report.
About PeerSense
PeerSense is an independent capital advisory firm in Westfield, Indiana. Our day-to-day work is placing senior debt for commercial real estate sponsors and business acquisition buyers — CMBS, bridge, hotel, DSCR rental, asset-based lending, equipment, factoring, and partner buyouts — on deals from $500,000 to $500 million.
That work means reading FDDs the way underwriters read them, modeling unit economics the way operators model them, and pricing risk the way capital markets price it. When a system shows up offering 120 territories with zero open locations and no Item 19, we recognize what we're looking at. That recognition produced this report.
In parallel, we operate a franchise intelligence database covering 6,300+ brands and 899+ SBA lenders — the dataset that made the Section 01 comparison table and the Investment Risk Memorandum possible.
PeerSense maintains franchise placement relationships with a small, select group of brands. None of the brands or principals named in this report falls into that group. No party named here has any past, present, or contemplated financial, advertising, or placement relationship with PeerSense.
Corrections, factual disputes, and right-of-reply submissions: info@peersense.com.